{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:29:03Z","timestamp":1790605743515,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>\n            We have reported that a high-salt (4.0% NaCl) dietary intake activates mTORC1 and inhibition of this pathway with rapamycin blunts the chronic phase of salt-induced hypertension and renal injury in Dahl salt-sensitive (SS) rats. In SS rats, high-salt intake is known to increase the renal production of H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            by NOX4, the most abundant NOX isoform in the kidney, and the global knockout of NOX4 blunts salt-sensitivity in these rats. Here, we explored the hypothesis that elevations of H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            by NOX4 in high-salt fed SS rat stimulate mTORC1 for the full development of salt-induced hypertension and renal injury. Our in vitro studies found that H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            activates mTORC1 independent of PI3K\/AKT and AMPK pathways. To determine the in vivo relevance of NOX4\/H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            \/mTORC1 in the salt-induced hypertension, SS-\n            <jats:italic>Nox4<\/jats:italic>\n            knockout (SS\n            <jats:sup>\n              <jats:italic>Nox4<\/jats:italic>\n              \u2212\/\u2212\n            <\/jats:sup>\n            ) rats were daily administrated with vehicle\/rapamycin fed a high-salt diet for 21 days. Rapamycin treatment of SS\n            <jats:sup>Nox4\u2212\/\u2212<\/jats:sup>\n            rats had shown no augmented effect on the salt-induced hypertension nor upon indices of renal injury. Significant reductions of renal T lymphocyte and macrophage together with inhibition of cell proliferation were observed in rapamycin treated rats suggesting a role of mTORC1 independent of NOX4 in the proliferation of immune cell. Given the direct activation of mTORC1 by H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            and absence of any further protection from salt-induced hypertension in rapamycin-treated SS\n            <jats:sup>\n              <jats:italic>Nox4<\/jats:italic>\n              \u2212\/\u2212\n            <\/jats:sup>\n            rats, we conclude that NOX4-H\n            <jats:sub>2<\/jats:sub>\n            O\n            <jats:sub>2<\/jats:sub>\n            is a major upstream activator of mTORC1 that contributes importantly to salt-induced hypertension and renal injury in the SS rat model.\n          <\/jats:p>","DOI":"10.1161\/hypertensionaha.120.15058","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T09:01:37Z","timestamp":1591002097000},"page":"133-143","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["NOX4\/H\n            <sub>2<\/sub>\n            O\n            <sub>2<\/sub>\n            \/mTORC1 Pathway in Salt-Induced Hypertension and Kidney Injury"],"prefix":"10.1161","volume":"76","author":[{"given":"Vikash","family":"Kumar","sequence":"first","affiliation":[{"name":"From the Department of Physiology, Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kurth","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezhda N.","family":"Zheleznova","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Allen W.","family":"Cowley","sequence":"additional","affiliation":[{"name":"From the Department of Physiology, Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.995802"},{"key":"e_1_3_4_3_2","first-page":"5689","article-title":"Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)\/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C.","volume":"62","author":"Huang C","year":"2002","unstructured":"Huang, C, Li, J, Ke, Q, Leonard, SS, Jiang, BH, Zhong, XS, Costa, M, Castranova, V, Shi, X. Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)\/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C. Cancer Res. 2002;62:5689\u20135697.","journal-title":"Cancer Res"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.46.32596"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09456"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12378"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2006.8.1597"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.11.007"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M502412200"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1504"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004581"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06280"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00187.2016"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00097.2015"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.199380"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.238014"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M506096200"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2009.03.001"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2008.08.013"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402352111"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1016"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2007.05.008"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.138818"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.011079"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00258.2014"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00454.2010"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.6.3589"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20160249"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13500"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep22455"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.302313"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7851327"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2016.30.4389"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.120.15058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:43:07Z","timestamp":1715596987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.120.15058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.120.15058"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.120.15058","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"2020-03-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}